Imaging programs reduce costs
Unnecessary diagnostic tests are harmful to patients and costly for health plans.
LOS ANGELES-Unnecessary diagnostic tests such as echocardiograms and computed tomography scans are harmful to patients and costly for health plans. Such tests can be avoided with the help of imaging management programs, according to an analysis from AIM Specialty Health and HealthCore, both WellPoint subsidiaries.
The analysis recorded a 12% overall reduction in the likelihood of follow-up tests, including myocardial perfusion imaging and cardiac CT scans.
The study hypothesized that members in plans with utilization management programs were less likely to have repeated imaging because the programs evaluate the need for the test against appropriateness criteria. Claims data from 96,906 commercially insured Anthem members in Indiana, Kentucky, Missouri, Ohio and Georgia was reviewed.
Allowing relevant factors such as age, gender, comorbidity, medication use, and cardiovascular event history, the repeat testing rate was lower for the managed group.
According to AIM, unnecessary testing has no positive impact on patient outcomes, and might have procedural risks and unnecessary radiation exposure. Studies published in 2010 and 2011 indicate that approximately 15% of cardiac imaging exams are inappropriate based on criteria established by the American College of Cardiology. -Miranda Hester
Premiums for Employer-based Health Insurance Increased by 7% in 2024, Says KFF Report
Published: October 9th 2024 | Updated: October 9th 2024The 2024 increase is the same as last year's increase for family coverage. The foundation’s annual survey of employer health benefits also found that only 18% of large employers (200 employees are more) are covering the GLP-1 weight loss drugs.
Read More
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More
Doug Chaet of Value Evolutions Discusses Value-based Payment Models, Where They Stand and More
September 29th 2022In this episode of Tuning In to the C-Suite, Managing Editor of Managed Healthcare Executive, Peter Wehrwein, speaks with President of Value Evolutions and MHE Editorial Advisory Board Member, Doug Chaet, FACHE, about value-based care's current standing, the status of select payment models like bundled and episodic, and more.
Listen
We conducted our annual State of the Industry survey in the early part of November 2023. The survey had 432 respondents, of whom 56% self-reported working for a payer organization (pharmacy benefit manager, insurer or self-insured employer), 34% for a provider organization and the remainder for government or an unspecified “other” category.
Read More
